Ah receptor signaling pathways

Annual Review of Cell and Developmental Biology
J V Schmidt, C A Bradfield

Abstract

The aryl hydrocarbon (Ah) receptor has occupied the attention of toxicologists for over two decades. Interest arose from the early observation that this soluble protein played key roles in the adaptive metabolic response to polycyclic aromatic hydrocarbons and in the toxic mechanism of halogenated dioxins and dibenzofurans. More recent investigations have provided a fairly clear picture of the primary adaptive signaling pathway, from agonist binding to the transcriptional activation of genes involved in the metabolism of xenobiotics. Structure-activity studies have provided an understanding of the pharmacology of this receptor; recombinant DNA approaches have identified the enhancer sequences through which this factor regulates gene expression; and functional analysis of cloned cDNAs has allowed the characterization of the major signaling components in this pathway. Our objective is to review the Ah receptor's role in regulation of xenobiotic metabolism and use this model as a framework for understanding the less well-characterized mechanism of dioxin toxicity. In addition, it is hoped that this information can serve as a model for future efforts to understand an emerging superfamily of related signaling pathways that control b...Continue Reading

References

Jan 1, 1979·Pharmacology & Therapeutics·R Snyder, H Remmer
Nov 1, 1978·Toxicology and Applied Pharmacology·R J KocibaC G Humiston
Apr 15, 1992·Biochemical and Biophysical Research Communications·M EmaY Fujii-Kuriyama
Jun 11, 1992·Proceedings of the National Academy of Sciences of the United States of America·L Wu, J P Whitlock
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K M BurbachC A Bradfield
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C V DangG J Kato
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G L SemenzaS E Antonarakis
Sep 1, 1990·Genes & Development·E N Olson
Oct 1, 1990·Molecular and Cellular Biology·K W Jones, J P Whitlock
Feb 1, 1989·Developmental Biology·J E Fitchett, E D Hay
Jun 15, 1989·Toxicology and Applied Pharmacology·B D Abbott, L S Birnbaum
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M S DenisonJ P Whitlock
Sep 15, 1988·Biochemical and Biophysical Research Communications·M DenisJ A Gustafsson
Jun 15, 1985·Toxicology and Applied Pharmacology·W F GreenleeR Osborne
Aug 14, 1987·Biochemical and Biophysical Research Communications·A Poland, E Glover
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A Fujisawa-SeharaY Fujii-Kuriyama

❮ Previous
Next ❯

Citations

Nov 21, 2000·Developmental Dynamics : an Official Publication of the American Association of Anatomists·B D Abbott, A R Buckalew
Dec 19, 2001·Developmental Dynamics : an Official Publication of the American Association of Anatomists·C D BelairW Heideman
Jun 16, 2010·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C Esser, J Krutmann
Feb 12, 2008·Analytical and Bioanalytical Chemistry·Daniela WengerRenato Zenobi
Jan 9, 2008·Archives of Environmental Contamination and Toxicology·Kentaro MisakiTomonari Matsuda
Aug 21, 2013·Seminars in Immunopathology·Charlotte EsserJean Krutmann
Mar 30, 2013·Environmental Science and Pollution Research International·Manhai LongEva Cecilie Bonefeld-Jørgensen
Apr 18, 2013·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Lan-Jun CaiZhong-Hua Klaus Chen
Jan 1, 2013·Environmental Health and Preventive Medicine·Sahoko Ichihara
Oct 3, 2013·Aquatic Toxicology·Lindsey V T GarnerRichard T Di Giulio
Mar 30, 2004·Biochemical and Biophysical Research Communications·Steven RoblinPatricia A Harper
Mar 31, 2004·Toxicology and Applied Pharmacology·Katerina ChramostováMiroslav Machala
Sep 15, 2004·Toxicology and Applied Pharmacology·Young C ChoColin R Jefcoate
Jun 8, 2002·Archives of Biochemistry and Biophysics·Christoph KöhleJacqueline McGuire
Sep 6, 2002·Chemico-biological Interactions·Michael S DenisonLaura Bonati
Sep 6, 2002·Chemico-biological Interactions·Yanan TianMichael A Gallo
Sep 6, 2002·Chemico-biological Interactions·Mark E Hahn
Feb 13, 1999·Fertility and Sterility·A KüchenhoffB Fischer
Oct 11, 2003·Toxicology and Applied Pharmacology·Soma S Ray, Hollie I Swanson
Jun 7, 2002·The Science of the Total Environment·Mark E Hahn
Feb 23, 2000·Pharmacology, Biochemistry, and Behavior·J T TuomistoJ Tuomisto
Jun 18, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R PohjanvirtaJ Tuomisto
Nov 25, 2000·Toxicology·C DelescluseR Rahmani

❮ Previous
Next ❯

Methods Mentioned

BETA
footprinting
nuclear translocation
dissection
immunoprecipitation
coimmunoprecipitation
two-hybrid

Software Mentioned

Sim

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Related Papers

Annual Review of Pharmacology and Toxicology
J P Whitlock
Proceedings of the National Academy of Sciences of the United States of America
J V SchmidtC A Bradfield
Proceedings of the National Academy of Sciences of the United States of America
G L WangG L Semenza
© 2021 Meta ULC. All rights reserved